Clinical Trial Update: Talampanel for Amyotrophic Lateral Sclerosis (ALS) [Phase 2]

View source ↗

Summary

Phase 2 trial of talampanel for amyotrophic lateral sclerosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Talampanel (talampanel)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: ALS | Phase 2 | Status: COMPLETED